Mizolastine-¹³C,d₃ 

Mizolastine-¹³C,d₃ is the ¹³C- and deuterium labeled Mizolastine.

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[81].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

436.50

C₂₃¹³CH₂₂D₃FN₆O

108612-45-9

O=C1NC(N(C2CCN(C3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)CC2)[13C]([2H])([2H])[2H])=NC=C1

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.  [Content Brief]

  [2]. Prakash A, et al. Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria. BioDrugs. 1998 Jul;10(1):41-63.  [Content Brief]